ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Superluminal Medicines, Inc.
Superluminal Medicines seeks a scientist to advance cryo-electron microscopy structural biology at its Bozeman, MT facility, focusing on membrane protein targets to accelerate small-molecule drug discovery. The role centers on producing high-resolution experimental structures and integrating structural insights into multidisciplinary drug discovery programs. The scientist will work closely with medicinal and computational chemistry teams to maximize the impact of structural data on program decisions.
Superluminal Medicines is a biotechnology company accelerating drug discovery and development to deliver next‑generation small‑molecule therapeutics. Their Hyperloop™ platform combines structure‑based drug design with AI‑driven computational methods and experimental validation to identify and optimize candidates. Initially focused on GPCR targets, their pipeline emphasizes patient‑centric precision to develop treatments for cardiometabolic diseases.
Business WireAxcelead DDP and Superluminal Announce the Intent to Collaborate on Drug Discovery Targeting Specific Molecular Mechanisms, continuing a productive relationship
Jun 23, 2025
BioWorld OnlineSuperluminal joins a $1.3B deal with series A backer Lilly
Aug 14, 2025
Citeline News & InsightsLilly Obesity Deal Gives Superluminal More Shots On GPCR Goals
Aug 28, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Superluminal Medicines, Inc..
Superluminal Medicines, Inc. didn’t post a salary, so this is our estimate from similar listings.
GlobeNewswireSuperluminal Medicines Closes $120 Million Series A Round
Sep 9, 2024
(Senior) Scientist, Cryo-EM Data Processing & Computational Workflows
Flagship Pioneering, Inc.
Senior Data Scientist
UK Centre for Ecology and Hydrology
Scientist II - Structural Biology
Nurix
Postdoctoral Research Associate in Membrane Protein Structural Biology
Iowa State University
Principal Scientist to Director, Structural Biology
Structure Therapeutics
Scientist in Discovery Science
Altos Labs
